The biology of inherited disorders of the gastrointestinal tract Part II: Pancreatic and hepatobiliary disorders

Journal of Pediatric Gastroenterology and Nutrition

Volumn 26, Issue 4, 1998, Pages 437-445

  Mart́n, Martín G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN;

ALAGILLE SYNDROME; CONGENITAL MALFORMATION; CRIGLER NAJJAR SYNDROME; DUBIN JOHNSON SYNDROME; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; GENETIC SUSCEPTIBILITY; GLYCOGEN STORAGE DISEASE; HEPATOBILIARY DISEASE; HOMEOBOX; NONSENSE MUTATION; OVARY POLYCYSTIC DISEASE; PANCREAS DISEASE; PANCREATITIS; PRIORITY JOURNAL; REVIEW; WILSON DISEASE;

BILE DUCT DISEASES; BILE DUCTS, INTRAHEPATIC; CHROMOSOME MAPPING; GASTROINTESTINAL DISEASES; HUMANS; PANCREATIC DISEASES;

EID: 0344541995     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199804000-00015     Document Type: Review

References (63)

1. Kinzler K, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
2. Scriver CR, Beaudet AL, Sly WS, Valle D. The metabolic and molecular bases of inherited disease. Vol 1-3. New York: McGraw-Hill, Health Professions Division, 1995.
3. Yamada T, Alpers DH, Owyang C, Powell DW, Silverstein FE. Textbook of gastroenterology. Philadelphia: Lippincott, 1995.
4. Mowat AP. Liver disorders in childhood. 3rd ed. Oxford and Boston: Butterworth-Heinemann, 1994.
5. Walker WA. Pediatric gastrointestinal disease: Pathophysiology, diagnosis, management. 2nd ed. St. Louis: Mosby, 1996.
6. Suchy FJ. Liver disease in children. 1st ed. St. Louis: Mosby, 1994.
7. PubMed. Bethesda, MD: National Center for Biotechnology Information, National Library of Medicine 1997. World Wide Web URL:http://www.ncbi.nlm.nih.gov/PubMed/.
8. Online Mendelian Inheritance in Man, OMIM. Baltimore, MD: Center for Medical Genetics, Johns Hopkins University. Bethesda, MD: National Center for Biotechnology Information, National Library of Medicine. 1996. World Wide Web URL: http://ww.ncbi.nlm.nih.gov/Omim/.
9. Whitcomb DC, Preston RA, Aston CE, et al. A gene for hereditary pancreatitis maps to chromosome 7q35. Gastroenterology 1996;110:1975-80.
10. Pandya A, Blanton SH, Landa B, et al. Linkage studies in a large kindred with hereditary pancreatitis confirms mapping of the gene to a 16-cM region on 7q. Genomics 1996;38:227-30.
11. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. 1996;14:141-5.
12. Harbecke R, Lengyel JA. Gemes controlling posterior gut development in the Drosophila embryo. Rouz Arch Dev Biol 1995;204: 308-29.
13. Pack M, Solnica-Krezel L, Malicki J, et al. Mutations affecting development of zebrafish digestive organs. Development 1996; 123:321-8.
14. Offield MF, Jetton T, Labosky PA, et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 1996;122:983-95.
15. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPFI gene coding sequence. Nat Genet 1997;5:106-10.
16. Vidal F, Aberdam D, Miquel C, et al. Integrin B4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet 1995;10:229-34.
17. Niessen CM, van der Raaij-Helmer LMH, Hulsman EHM, va der Neut R, Jonkman MF, Sonnenberg A. Deficiency of the integrin B4 subunit in junctional epidermolysis bullosa with pyloric atresia: Consequences for hemidesmosome formation and adhesion properties. J Cell Sci 1996;109:1695-706.
18. Georges-Labouesse E, Messaddeq N, Yehia G, Cadalbert L, Dierich A, Le Meur M. Absence of integrin α6 leads to epidermolysis bullosa and neonatal death in mice. Nat Genet 1996;13:370-3.
19. Ruzzi L, Gagnoux-Palacios L, Pinola M, et al. A heterozygous mutation in the integrin α6 gene in junctional epidermolysis bullosa with pyloric atresia. J Clin Invest 1997;99:2826-31.
20. Levy EN, Shen Y, Kupelian A, et al. Linkage disequilibrium mapping places the gene causing familial Mediterranean fever close to D16S246. Am J Hum Genet 1996;58:523-34.
21. The French FMF Consortium. Localization of the familial Mediterranean fever gene (FMF) to a 250-kb interval in non-Ashkenazi Jewish founder haplotypes. Am J Hum Genet 1996;59:603-12.
22. The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997;17:25-31.
23. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997;90:797-807.
24. Meissner PN, Dailey TA, Hift R, et al. A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria. Nat Genet 1996;13:95-7.
25. Deybach JC, Puy H, Robrau AM, et al. Mutations in the protoporphyrinogen oxidase gene in patients with variegate porphyria. Hum Mol Genet 1996;5:407-10.
26. Lindberg RLP, Porcher C, Grandchamp B, et al. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria. Nat Genet 1996;12:195-9.
27. Carlton VEH, Knisely AS, Freimer NB. Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region. Hum Mol Genet 1995;4:1049-53.
28. Sinke RJ, Carlton VE, Juijn JA, et al. Benign recurrent intrahepatic cholestasis (BRIC): Evidence of genetic heterogeneity and delimitation of the BRIC locus to a 7-cmM interval between D18S69 and D18S64. Hum Genet 1997;100:382-7.
29. Strautnieks SS, Kagalwalla AF, Tanner MS, Gardiner RM, Thompson RJ. Locus heterogeneity in progressive familial intrahepatic cholestasis. J Med Genet 1996;33:833-6.
30. Arnell H, Nemeth A, Anneren G, Dahl N. Progressive familial intrahepatic cholestasis (PFIC): Evidence for genetic heterogeneity by exclusion of linkage to chromosome 18q21-q22. Hum Genet 1997;100:378-81.
31. Strautnieks S, Kagalwalla AF, Tanner MS, et al. Identification of a second locus for progressive familial intrahepatic cholestasis on chromosome 2q24 (abstract). Med Genet 1997;9:16.
32. Bull LN, Carlton VE, Stricker NL, et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology 1997;26:155-64.
33. Smit JJM, Schinkel AH, Oude Elferink RPJ, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993;75:451-62.
34. Deleuze J, Jacquemin E, Dubuisson C, et al. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 1996;23:904-8.
35. Keppler D, Konig J. Hepatic canalicular membrane 5: Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J 1997;11:509-16.
36. Paulusma CC, Bosma PJ, Zaman GJR, et al. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 1996;271:1126-8.
37. Ito K, Suzuki H, Hirohashi T, Kume K, Shimizu T, Sugiyama Y. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am J Physiol 1997;272:G16-22.
38. Paulusma CC, Kool M, Bosma PJ, et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 1997;25:1539-42.
39. Ciotti M, Obaray R, Martin MG, Owens IS. Genetic defects at the UGT1 locus associated with Crigler-Najjar type I disease, including a prenatal diagnosis. Am J Med Genet 1997;68:173-8.
40. Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome (see comments). N Engl J Med 1995; 333:1171-5.
41. Soeda Y, Yamamoto K, Adachi Y, et al. Predicted homozygous missense mutation in Gilbert's syndrome. Lancer 1995;346:1494.
42. Loudianos G, Dessi V, Angius A, et al. Wilson disease mutations associated with uncommon haplotypes in Mediterranean patients. Hum Genet 1996;98:640-2.
43. Schilsky ML. Wilson disease: Genetic basis of copper toxicity and natural history. Semin Liver Dis 1996;16:83-95.
44. Theophilos MB, Cox DW, Mercer JFB. The toxic milk mouse is a murine model of Wilson disease. Hum Mol Genet 1996;5:1619-24.
45. Chevalier-Porst F, Bozon D, Bonardort AM, et al. Mutation analysis in 24 French patients with glycogen storage disease type 1a. J Med Genet 1996;33:358-60.
46. Lei KJ, Chen HW, Pan CI, et al. Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse. Nat Genet 1996;13:203-9.
47. Shen JJ, Bao Y, Liu HM, Lee P, Leonard JV, Chen YT. Mutations in exon 3 of the glycogen debranching enzyme gene associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest 1996;98:352-357.
48. Shen JJ, Liu HM, Bao Y, Chen YT. Polymorphic markers of the glycogen debranching enzyme gene allowing linkage in families with glycogen storage disease type III. J Med Genet 1997;34:34-38.
49. Isaacs JD, Sims H, Powell CK, et al. Maternal acute fatty liver of pregnancy associated with fetal trifunctional protein deficiency: Molecular characterization of a novel maternal mutant allele. Pediatr Res 1997;16:235-42.
50. Bakker HD, Scholte HR, Dingemans KP, et al. Depletion of mitochondrial deoxyribonucleic acid in a family with fatal neonatal liver disease. Journal of Pediatrics 1996;128:683-7.
51. Handig I, Dams E, Taroni F, et al. Inheritance of the S113L mutation within an inbred family with carnitine palmitoyl transferase enzyme deficiency. Human Genetics 1996;97:291-3.
52. Alagille D. Alagille Syndrome today. Clin Invest Med 1996;19: 325-30.
53. Li L, Krantz ID, Deng Y, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for notch 1. Nat Genet 1997;16:243-51.
54. Oda T, Elkahloun AG, Pike BL, et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 1997;16:235-42.
55. Artavanis-Tsakonas S. Alagille syndrome-a notch up for the Notch receptor. Nat Genet 1997;16:212-3.
56. Nye JS, Kopan R. Developmental signaling: Venebrate ligands for Notch. Curr Biol 1995;5:966-9.
57. Lieber T, Wesley CS, Alcamo E, et al. Single amino acid substitutions in EGF-like elements of Notch and Delta modify Drosophila development and affect cell adhesion in vitro. Neuron 1992;9:847-59.
58. Kelley MR, Kidd S, Deutsch WA, Young MW. Mutations altering the structure of epidermal growth factor-like coding sequences at the Drosophila Notch locus. Cell 1987;51:539-48.
59. International Polycystic Kidney Disease Consort. Polycystic kidney disease: The complete structure of the PKD1 gene and its protein. Cell 1995;81:289-98.
60. Peral B, Millan JL, Ong ACM, Gamble V, Ward CJ, Strong C, Harris PC. Screening the 3' region of the Polycystic Kidney Disease 1 (PKD1) gene reveals six novel mutations. Am J Hum Genet 1997;58:86-96.
61. Qian F, Watnick TJ, Onuchic LF, Germino GG. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 1996;87:979-87.
62. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Somlo S. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996;272:1339-42.
63. Qian F, Germino FJ, Cai Y, Zhang X, Somlo S, Germino GG. PKD1 interacts with PKD2 through a probable coiled-coil domain. 1997;16:179-83.